Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi, 329-0498, Japan Keita Suto, Akira Saito, Katsusuke Mori, Atsushi Yoshida & Naohiro Sata Contributions All authors have all contributed as authors...
From March 2020, there was a statistically significant deterioration in availability to gastroenterological treatment compared with the time before the pandemic (P<0.05). Overall, 51.90% (42/81; CD-y 4/8; CD-o 7/14; UC-y 11/17; and UC-o 20/42) of respondents reported a problem in tr...
Long- COVID and general health status in hospitalized COVID-19 survivors Article Open access 19 May 2023 Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA) Article Open access 11 March 2023 Introduction...
Corticosteroids are used in several inflammatory conditions affecting a wide range of system, including dermatological, ophthalmic, rheumatologic, hematologic, gastroenterological and others. More importantly, they are commonly used in pulmonary infections like asthma, chronic obstructive pulmonary disease and ...
Improvement or palliation of symptoms Within 1-8 weeks 69.2 Avoidance of major surgery and/or hospitalization Within 1-8 weeks 75 Avoidance of cancer/cancer progression; avoidance of major surgery and/or hospitalization Defer >8 weeks, and reassess timing 100 ∗ No consensus achieved on the fi...
(currently a professor and chair at the Division of Infectious Diseases, Respiratory and Gastroenterological Medicine (First Department of Internal Medicine), University of the Ryukyus Graduate School of Medicine). This is a multicenter, double-blinded, randomized controlled trial conducted at Nagasaki ...
Although respiratory transmission and symptoms are still the essential manifestations of COVID-19, the digestive system could be an unconventional or ... EJ Despott - 《Gastroenterological Endoscopy》 被引量: 0发表: 2021年 Feasibility of an integrated approach to the treatment of liver diseases in...
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: Systematic review and meta-analysis. BMJ Open Gastroenterol. 2021, 8, e000571. [Google Scholar] [CrossRef] [PubMed] Milano, A.; Efthymakis, K.; D’...
patients have not reported a higher prevalence of COVID-19 compared to the general population, IBD-related use of glucocorticoids (but not anti-TNF-alpha treatment) may be associated with a higher risk of a more severe COVID-19 infection in this subgroup of gastroenterological patients [32,33...
]. The American Gastroenterological Association (AGA) addressed this matter [25] by categorizing the HBVr risk induced by immunosuppressants as high when the risk of reactivation is expected to be more than 10%, moderate when the frequency of reactivation is between 1% and 10% and low when ...